Sleep apnea predicts cardiovascular death in patients with Marfan syndrome: a cohort study.

"Declarations Ethics approvalAll procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Hamburg research ethics committee approved our protocol (17 Oct 2008, PV3031). All patients provided written informed consent. Consent to participateAll patients provided written informed consent. Consent for publicationNot applicable. Competing interestsNG reports grants from Boston Scientific, grants from Medtronic, and support from Bayer Vital, outside the submitted work.SD reports institutional grants from COOK Medical and honoraria from Bayer Vital, outside the submitted work.CE reports grants and/or personal fees from Abbott, Biosense Webster, Biotronik, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Daiichi Sankyo and Medtronic, outside the submitted work.SH reports grants from Meril Life, Boston Scientific and Spectranetics, outside the submitted work.ET reports honoraria from Abiomed and travel compensation from Bayer Vital, Edwards, and Amgen, outside the submitted work.SW reports grants and personal fees from Abbott, Boston Scientific, and Medtronic, and personal feels from Abbott, Boehringer Ingelheim, Bristol Myers Squibb, Bayer Vital, Acutus, and Daiichi Sankyo, outside the submitted work.All other authors have nothing to disclose. Competing interests NG reports grants from Boston Scientific, grants from Medtronic, and support from Bayer Vital, outside the submitted work. SD reports institutional grants from COOK Medical and honoraria from Bayer Vital, outside the submitted work. CE reports grants and/or personal fees from Abbott, Biosense Webster, Biotronik, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Daiichi Sankyo and Medtronic, outside the submitted work. SH reports grants from Meril Life, Boston Scientific and Spectranetics, outside the submitted work. ET reports honoraria from Abiomed and travel compensation from Bayer Vital, Edwards, and Amgen, outside the submitted work. SW reports grants and personal fees from Abbott, Boston Scientific, and Medtronic, and personal feels from Abbott, Boehringer Ingelheim, Bristol Myers Squibb, Bayer Vital, Acutus, and Daiichi Sankyo, outside the submitted work. All other authors have nothing to disclose."

"Declarations: Ethics approvalAll procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Hamburg research ethics committee approved our protocol (17 Oct 2008, PV3031). All patients provided written informed consent.: Consent to participateAll patients provided written informed consent.: Consent for publicationNot applicable.: Competing interestsNG reports grants from Boston Scientific, grants from Medtronic, and support from Bayer Vital, outside the submitted work.SD reports institutional grants from COOK Medical and honoraria from Bayer Vital, outside the submitted work.CE reports grants and/or personal fees from Abbott, Biosense Webster, Biotronik, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Daiichi Sankyo and Medtronic, outside the submitted work.SH reports grants from Meril Life, Boston Scientific and Spectranetics, outside the submitted work.ET reports honoraria from Abiomed and travel compensation from Bayer Vital, Edwards, and Amgen, outside the submitted work.SW reports grants and personal fees from Abbott, Boston Scientific, and Medtronic, and personal feels from Abbott, Boehringer Ingelheim, Bristol Myers Squibb, Bayer Vital, Acutus, and Daiichi Sankyo, outside the submitted work.All other authors have nothing to disclose."